Ledger.Open graph →

SEC Form D · filed December 29, 2020

Dialectic Therapeutics, Inc

Offering

$5.0M

Sold

$2.9M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

DALLAS, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Joshua D. Sills · Dallas, TXExec John D. Harkey · Dallas, TXDirector Daohong Zhou · Dallas, FLDirector Robert Hromas · Dallas, TXDirector David Genecov · Dallas, TXExec · Director Stephen Cash · New York, NYExec Duncan Davidson · SEATTLE, WADirector James Maiocco · SEATTLE, WADirector Kathy Chill · SEATTLE, WADirector Janelle Maiocco · SEATTLE, WAExec · Director Dan Schulte · Overland Park, KSExec Daniel Mafrice · Nashville, TNDirector Carl Farrell · Encino, Los Angeles, CAExec · Director Sajid Premji · Encino, Los Angeles, CADirector Paula Madison · Encino, Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗